Absence of variation of non-TP53 mutations in HSPC of TP53-mutated MPN patients upon MDM2 inhibitor treatment. Comparison of VAFs for mutations found in other genes in CD34⁺ cells of the same MPN patients. **P < .01 using a Student t test for statistical comparison. NT, not treated.